美股A股
StockGist
Back
8-K2026-03-11· grok-4-1-fast-non-reasoning

OGEN · Oragenics, Inc.

0001493152-26-009682

SEC filing

Summary

Oragenics, Inc. issued a press release on March 10, 2026, announcing receipt of final Human Research Ethics Committee approval. The company filed an 8-K on March 11, 2026, under Item 8.01 Other Information with exhibits including press releases dated March 10 and March 11, 2026.

Key takeaways